See more : Texas Capital Bancshares, Inc. (TCBI) Income Statement Analysis – Financial Results
Complete financial analysis of AlzChem Group AG (ALZCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AlzChem Group AG, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Slitevind AB (SLITE.ST) Income Statement Analysis – Financial Results
- Huaxin Cement Co., Ltd. (6655.HK) Income Statement Analysis – Financial Results
- Temecula Valley Bancorp Inc. (TMCV) Income Statement Analysis – Financial Results
- LOUD Technologies Inc. (LTEC) Income Statement Analysis – Financial Results
- Visagar Polytex Limited (VIVIDHA.BO) Income Statement Analysis – Financial Results
AlzChem Group AG (ALZCF)
About AlzChem Group AG
AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 540.65M | 542.22M | 422.29M | 379.26M | 376.07M | 375.22M | 353.92M | 327.19M | 329.21M | 298.36M | 301.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 241.72M | 259.50M | 153.96M | 128.68M | 138.79M | 143.05M | 129.94M | 241.40M | 144.30M | 127.60M | 133.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 298.93M | 282.72M | 268.34M | 250.58M | 237.28M | 232.17M | 223.98M | 85.78M | 184.91M | 170.76M | 168.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 55.29% | 52.14% | 63.54% | 66.07% | 63.09% | 61.88% | 63.28% | 26.22% | 56.17% | 57.23% | 55.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 11.41M | 10.79M | 9.69M | 9.36M | 9.31M | 8.68M | 9.02M | 8.66M | 8.60M | 7.99M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 12.73M | 11.35M | 11.17M | 17.08M | 17.73M | 17.79M | 18.93M | 40.38M | -1.01M | 96.51M | 92.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 21.05M | 28.27M | 18.03M | 14.89M | 16.38M | 19.55M | 16.50M | 997.00K | 1.04M | 1.03M | 930.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 149.35M | 39.62M | 29.20M | 31.97M | 34.11M | 37.35M | 35.43M | 41.38M | 30.86K | 97.55M | 93.01M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 0.00 | -9.54M | -8.43M | -9.29M | -8.15M | -10.00M | -9.32M | -7.96M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 160.77M | 252.16M | 230.80M | 218.07M | 207.03M | 192.41M | 190.14M | 28.37K | 30.86K | 9.82K | 4.43K | 3.75K | 5.12K | 12.56K | 5.31K | 5.13K |
Cost & Expenses | 402.48M | 511.66M | 384.75M | 346.74M | 345.82M | 335.46M | 320.09M | 28.37K | 30.86K | 9.82K | 4.43K | 3.75K | 5.12K | 12.56K | 5.31K | 5.13K |
Interest Income | 321.00K | 7.70M | 643.00K | 7.00K | 117.00K | 203.00K | 377.00K | 0.00 | 0.18 | 0.37 | 0.52 | 0.35 | 490.07 | 1.61K | 24.21 | 0.00 |
Interest Expense | 7.66M | 3.03M | 1.70M | 3.81M | 5.36M | 2.67M | 3.00M | 383.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 25.90M | 25.54M | 24.47M | 23.10M | 19.49M | 15.19M | 13.99M | 13.03M | -0.18 | -0.37 | -0.52 | -0.35 | 0.00 | 0.00 | 0.00 | 0.00 |
EBITDA | 81.75M | 69.86M | 62.68M | 54.13M | 50.34M | 49.77M | 46.32M | 43.21M | -31.00K | -10.00K | -9.00K | -3.75K | -5.12K | -12.56K | -5.31K | -5.13K |
EBITDA Ratio | 15.12% | 11.92% | 14.84% | 14.27% | 13.39% | 14.81% | 13.05% | -0.01% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 143.30M | 61.44M | 38.22M | 31.01M | 30.85M | 40.39M | 32.19M | -28.37K | -30.86K | -9.82K | -4.43K | -3.75K | -5.12K | -12.56K | -5.31K | -5.13K |
Operating Income Ratio | 26.51% | 11.33% | 9.05% | 8.18% | 8.20% | 10.76% | 9.09% | -0.01% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -95.12M | -20.16M | -25.53M | -74.94M | -4.35M | -7.59M | -4.24M | 21.91M | -52.67M | 0.00 | 0.00 | 0.00 | 0.00 | 1.61K | 24.21 | 317.09 |
Income Before Tax | 48.19M | 41.28M | 36.51M | 27.20M | 25.49M | 31.92M | 29.34M | -28.75K | -30.86K | -9.82K | -4.43K | -3.75K | -4.63K | -10.95K | -5.28K | -4.82K |
Income Before Tax Ratio | 8.91% | 7.61% | 8.65% | 7.17% | 6.78% | 8.51% | 8.29% | -0.01% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 13.40M | 11.06M | 8.75M | 7.33M | 7.35M | 9.14M | 8.76M | 6.60M | 0.06 | -1.78K | 6.92M | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | 34.62M | 30.05M | 27.59M | 19.69M | 17.98M | 22.64M | 20.39M | -28.75K | -30.86K | -8.04K | -4.43K | -3.75K | -4.63K | -10.95K | -5.28K | -4.82K |
Net Income Ratio | 6.40% | 5.54% | 6.53% | 5.19% | 4.78% | 6.03% | 5.76% | -0.01% | -0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 3.40 | 2.97 | 2.72 | 1.94 | 1.77 | 2.23 | 2.00 | -0.13 | -0.14 | -0.04 | -0.02 | -0.03 | -0.02 | -0.05 | 0.00 | 0.00 |
EPS Diluted | 3.40 | 2.97 | 2.72 | 1.94 | 1.77 | 2.23 | 2.00 | -0.13 | -0.14 | -0.04 | -0.02 | -0.03 | -0.02 | -0.05 | 0.00 | 0.00 |
Weighted Avg Shares Out | 10.17M | 10.14M | 10.15M | 10.18M | 10.18M | 10.18M | 10.18M | 223.29K | 223.29K | 223.29K | 223.29K | 0.00 | 223.29K | 223.29K | 0.00 | 0.00 |
Weighted Avg Shares Out (Dil) | 10.17M | 10.14M | 10.15M | 10.18M | 10.18M | 10.18M | 10.18M | 223.29K | 223.29K | 223.29K | 223.29K | 0.00 | 223.29K | 223.29K | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports